1. Academic Validation
  2. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri

Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri

  • J Nat Prod. 1996 Feb;59(2):196-9. doi: 10.1021/np9600560.
J Qian-Cutrone 1 S Huang J Trimble H Li P F Lin M Alam S E Klohr K F Kadow
Affiliations

Affiliation

  • 1 Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.
Abstract

During the screening of natural products for their ability to inhibit the binding of HIV-REV protein to [33P]-labeled RRE RNA, one novel compound, niruriside (1), was isolated from the MeOH extract of the dried leaf of Phyllanthus niruri L. by bioassay-guided fractionation. The structure of niruriside was determined by spectroscopic methods. Niruriside showed specific inhibitory activity against the binding of REV protein to RRE RNA with an IC50 value of 3.3 microM; however, niruriside did not protect CEM-SS cells from acute HIV Infection at concentrations up to 260 microM using an XTT dye reduction assay.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-165513
    HIV REV/RRE相互作用抑制剂
    HIV